TRiCares
PrivateLast Round
Series D
Jul 25, 2024
Total Funding Raised
$154.44M
Company Overview
TRiCares is a surgical devices company that develops a catheter-based valve replacement system for the minimally invasive treatment of tricuspid valve regurgitation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TRiCares Comparables
Compare TRiCares with similar companies based on industry and business-model similarity.
TRiCares Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jul 25, 2024 | ||||
| Debt | Jan 20, 2024 | ||||
| Series C | Dec 6, 2022 | ||||
| Series B | Jun 4, 2018 |
Key People
Founding team and executive leadership
TRiCares Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioMedPartners | Series C, Series B |
| Andera Partners | Series C, Series B |
| 415 Capital | Series C |
| European Investment Bank Group | Debt |
| GO Capital | Series C, Seed, Series B |
| Crédit Mutuel Innovation | Series C, Seed, Series B |
| Wellington Partners | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors grew 140% MoM, reaching 1.9K.
- Mar 16, 2025
Monthly visitors grew 223% MoM, reaching 2.9K.
TRiCares Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about TRiCares's valuation, stock price, and market status.
Is TRiCares a public or private company?
TRiCares is a private company.
What is the current stock price of TRiCares?
TRiCares is a private company with no public stock price. No recent secondary market data is available.
How much is TRiCares worth (valuation)?
Valuation information for TRiCares is not publicly available.
Can I buy TRiCares stock?
TRiCares shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was TRiCares's last funding round?
TRiCares's most recent funding round was Series D on July 25, 2024.
Who are the main investors in TRiCares?
Key investors in TRiCares include BioMedPartners, Andera Partners, 415 Capital, Wellington Partners.
Will TRiCares IPO soon?
No public IPO plans have been announced for TRiCares.
How can I track TRiCares secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TRiCares's secondary market activity and sign up for updates.